Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 80.91%10.4B | 86.38%9.38B | 98.04%8.91B | 16.13%5.75B | 16.13%5.75B | 19.94%5.21B | 26.72%5.03B | 26.18%4.5B | 34.06%4.95B | 34.06%4.95B |
-Cash and cash equivalents | 80.91%10.4B | 86.38%9.38B | 98.04%8.91B | 16.13%5.75B | 16.13%5.75B | 19.94%5.21B | 26.72%5.03B | 26.18%4.5B | 34.06%4.95B | 34.06%4.95B |
Receivables | -6.18%1.34B | -6.33%1.55B | -15.47%1.46B | 1.14%1.43B | 1.14%1.43B | 8.45%1.49B | 14.48%1.66B | 37.91%1.73B | 12.67%1.41B | 12.67%1.41B |
-Accounts receivable | -6.18%1.34B | -6.33%1.55B | -15.47%1.46B | 1.14%1.43B | 1.14%1.43B | 8.45%1.49B | 14.48%1.66B | 37.91%1.73B | 12.67%1.41B | 12.67%1.41B |
-Gross accounts receivable | -6.18%1.34B | -6.33%1.55B | -15.47%1.46B | 1.14%1.43B | 1.14%1.43B | 8.45%1.49B | 14.48%1.66B | 37.91%1.73B | 12.67%1.41B | 12.67%1.41B |
Inventory | -29.30%6.95M | 15.48%8.31M | 4.05%16.12M | 108.91%9.83M | 108.91%9.83M | -23.41%15.16M | -13.58%7.2M | -3.19%15.5M | -18.05%4.7M | -18.05%4.7M |
Other current assets | -44.40%118.84M | -21.74%194.67M | -1.45%223.41M | 53.05%213.73M | 53.05%213.73M | 125.10%246.62M | 109.89%248.75M | 132.96%226.7M | 110.53%139.65M | 110.53%139.65M |
Total current assets | 60.32%11.87B | 60.31%11.13B | 63.96%10.61B | 13.73%7.4B | 13.73%7.4B | 19.06%6.97B | 25.24%6.94B | 31.18%6.47B | 29.66%6.51B | 29.66%6.51B |
Non current assets | ||||||||||
Net PPE | -7.63%970.82M | -2.85%1.01B | -1.85%1.04B | 2.59%1.05B | 2.59%1.05B | 70.36%1.07B | 75.18%1.04B | 107.51%1.06B | 15.20%1.02B | 15.20%1.02B |
-Gross PP&E | -4.07%1.44B | -2.85%1.01B | -1.85%1.04B | 7.09%1.5B | 7.09%1.5B | 70.36%1.07B | 75.18%1.04B | 107.51%1.06B | 15.29%1.4B | 15.29%1.4B |
-Accumulated depreciation | -4.19%-472.35M | ---- | ---- | -19.20%-453.36M | -19.20%-453.36M | ---- | ---- | ---- | -15.53%-380.33M | -15.53%-380.33M |
Goodwill and other intangible assets | -23.23%417.55M | -19.76%490.91M | -21.54%507.59M | -19.37%543.92M | -19.37%543.92M | -18.50%580.1M | -18.32%611.83M | -17.72%646.94M | -17.64%674.58M | -17.64%674.58M |
-Goodwill | -25.00%288.76M | -22.22%336.89M | -21.05%360.95M | -20.00%385.02M | -20.00%385.02M | -19.05%409.08M | -18.18%433.14M | -17.39%457.21M | -16.81%481.27M | -16.81%481.27M |
-Other intangible assets | -18.95%128.79M | -13.81%154.02M | -22.72%146.63M | -17.80%158.9M | -17.80%158.9M | -17.17%171.02M | -18.64%178.69M | -18.50%189.73M | -19.64%193.31M | -19.64%193.31M |
Deferred tax assets-non current | -9.19%87.24M | ---- | ---- | -46.65%96.07M | -46.65%96.07M | ---- | ---- | ---- | 93.03%180.06M | 93.03%180.06M |
Other non current assets | -19.51%14.48M | -28.96%94.31M | -56.27%63.86M | -27.99%17.99M | -27.99%17.99M | --102.47M | --132.75M | --146.05M | 148.56%24.98M | 148.56%24.98M |
Total non current assets | -12.81%1.49B | -10.57%1.6B | -13.04%1.61B | -10.25%1.71B | -10.25%1.71B | -9.98%1.76B | -10.86%1.79B | 3.21%1.85B | 5.10%1.9B | 5.10%1.9B |
Total assets | 46.61%13.36B | 45.79%12.73B | 46.85%12.22B | 8.31%9.11B | 8.31%9.11B | 11.80%8.73B | 15.65%8.73B | 23.73%8.32B | 23.15%8.41B | 23.15%8.41B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 28.52%1.46B | -6.03%1.23B | -4.22%1.11B | -15.90%1.14B | -15.90%1.14B | -2.25%1.14B | 4.53%1.31B | 15.37%1.16B | -3.37%1.35B | -3.37%1.35B |
-accounts payable | -28.93%3.43M | -6.91%4.45M | 58.25%4.31M | -23.62%4.83M | -23.62%4.83M | 37.36%6.06M | 2.58%4.78M | -29.29%2.72M | 73.89%6.33M | 73.89%6.33M |
-Total tax payable | 102.04%646.76M | -4.27%450.28M | 15.27%286.74M | -43.51%320.11M | -43.51%320.11M | -6.34%285.98M | -1.42%470.36M | 1.54%248.76M | -13.34%566.67M | -13.34%566.67M |
-Other payable | -0.13%810.69M | -7.02%771.86M | -9.77%815.6M | 4.26%811.76M | 4.26%811.76M | -0.99%847.68M | 8.25%830.11M | 20.10%903.86M | 5.05%778.58M | 5.05%778.58M |
Pension and other retirement benefit plans | 84.82%90.51M | 38.92%89.97M | 3.16%39.07M | -53.06%48.97M | -53.06%48.97M | -48.96%26.86M | -44.97%64.77M | -29.08%37.87M | 1.27%104.33M | 1.27%104.33M |
Accrued and deferred income | 73.77%14.24M | 34.79%14.21M | 50.30%8.04M | -46.84%8.19M | -46.84%8.19M | -31.70%5M | -43.82%10.54M | -42.22%5.35M | -4.64%15.41M | -4.64%15.41M |
Other current liabilities | -28.21%159.38M | 47.88%218.12M | -10.89%216.7M | 66.16%222M | 66.16%222M | 22.54%151.88M | 26.67%147.5M | 15.13%243.18M | 27.48%133.61M | 27.48%133.61M |
Current liabilities | 21.83%1.73B | 1.36%1.55B | -4.95%1.37B | -11.78%1.42B | -11.78%1.42B | -1.95%1.32B | 1.76%1.53B | 13.05%1.44B | -1.09%1.6B | -1.09%1.6B |
Non current liabilities | ||||||||||
Long term pension and other post-retirement benefit plans | -21.34%117.96M | 8.96%170.04M | 3.41%153.77M | 6.10%149.96M | 6.10%149.96M | 21.96%163.41M | 23.23%156.05M | 26.87%148.7M | 26.29%141.34M | 26.29%141.34M |
Other non current liabilities | -29.65%113.24M | -22.21%124.06M | -17.16%138.79M | -13.00%160.96M | -13.00%160.96M | -13.35%160.99M | -12.82%159.48M | -6.52%167.54M | -1.38%185.02M | -1.38%185.02M |
Total non current liabilities | -25.64%231.2M | -6.79%294.1M | -7.49%292.55M | -4.73%310.92M | -4.73%310.92M | 1.44%324.39M | 1.93%315.53M | 6.68%316.23M | 8.96%326.36M | 8.96%326.36M |
Total liabilities | 13.29%1.96B | -0.03%1.84B | -5.40%1.66B | -10.59%1.73B | -10.59%1.73B | -1.30%1.65B | 1.79%1.84B | 11.85%1.76B | 0.47%1.93B | 0.47%1.93B |
Shareholders'equity | ||||||||||
Share capital | 440.14%1.97B | 440.14%1.97B | 440.14%1.97B | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M |
-common stock | 440.14%1.97B | 440.14%1.97B | 440.14%1.97B | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M | 0.00%364.28M |
Additional paid-in capital | 417.61%1.99B | 418.85%1.99B | 420.22%1.99B | 0.54%384.45M | 0.54%384.45M | 0.71%383.97M | 0.67%383.4M | 2.96%382.89M | 3.19%382.38M | 3.19%382.38M |
Retained earnings | 10.81%8.13B | 12.53%7.6B | 13.19%7.28B | 15.50%7.33B | 15.50%7.33B | 17.16%7.03B | 20.13%6.76B | 27.63%6.44B | 32.21%6.35B | 32.21%6.35B |
Less: Treasury stock | -1.97%714.94M | 11.72%714.23M | 14.15%729.77M | 14.08%729.3M | 14.08%729.3M | 14.19%729.2M | 0.11%639.3M | 1.44%639.3M | 1.53%639.3M | 1.53%639.3M |
Other reserves | 5.56%35.83M | 78.02%41.77M | 110.71%43.57M | 26.74%33.94M | 26.74%33.94M | 3.67%26.64M | 176.43%23.46M | 238.29%20.68M | 716.93%26.78M | 716.93%26.78M |
Total stockholders'equity | 54.40%11.4B | 58.06%10.89B | 60.84%10.56B | 13.94%7.39B | 13.94%7.39B | 15.37%7.08B | 20.02%6.89B | 27.35%6.56B | 32.02%6.48B | 32.02%6.48B |
Total equity | 54.40%11.4B | 58.06%10.89B | 60.84%10.56B | 13.94%7.39B | 13.94%7.39B | 15.37%7.08B | 20.02%6.89B | 27.35%6.56B | 32.02%6.48B | 32.02%6.48B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |